Skip to content

MDMA clinical trials: pipeline by phase and status

Every trial in this library's ClinicalTrials.gov slice that names MDMA: 115 registered studies, grouped by phase and by recruitment status. For the published research, see the MDMA research page.

The pipeline at a glance

By phase
PhaseTrials
Early phase 1 10
Phase 1 32
Phase 1/2 3
Phase 2 43
Phase 2/3 1
Phase 3 7
Not applicable 12
Unspecified 7
By status
StatusTrials
Recruiting or planned 32
Active, not recruiting 2
Completed 66
Stopped 10
Unknown or other 5

5,056 participants across the 114 trials that report enrollment. The earliest registered start is 2001, and 30 trials started in the last two years.

Most active sponsors

  • Resilient Pharmaceuticals 28 trials
  • University Hospital, Basel, Switzerland 23 trials
  • University of Chicago 7 trials
  • California Pacific Medical Center Research Institute 2 trials
  • Emory University 2 trials

Evidence by condition

All 115 trials

Most advanced phase first, and within each phase the most recent start date first.

Phase 3 7 trials

Phase 2/3 1 trial

Phase 2 43 trials

Phase 1/2 3 trials

Phase 1 32 trials

Early phase 1 10 trials

Not applicable 12 trials

Unspecified 7 trials

Data from ClinicalTrials.gov (opens in new tab), refreshed daily. Browse all clinical trials.